Urology Times - BPH news, treatments, and more. - UrologyTimes

ADVERTISEMENT

ADVERTISEMENT

BPH
  • FDA gives nod to combination treatment for BPH


    FDA has approved the 5-alpha-reductase inhibitor dutasteride (Avodart) in combination with the alpha-blocker tamsulosin (Flomax) for treatment of symptomatic enlarged prostate. Both drugs had previously been approved individually for treatment of enlarged prostate.

    Therapy combination superior in high-risk BPH patients



    The combination of dutasteride (Avodart) and tamsulosin (Flomax) provides significantly greater improvement in International Prostate Symptom Score (IPSS) and patient-reported quality of life than either therapy alone in men with BPH who are at increased risk of progression.

    Alpha-blocker raises success of trial without catheter


    A trial without catheter (TWOC) following an average of 3 days of catheterization has become standard practice in men with acute urinary retention (AUR) associated with BPH. Now, the results of a recent study have shown that the administration of an alpha-blocker prior to a TWOC can significantly increase the chances of the success of TWOC.

    Two-drug combination superior in high-risk BPH patients


    The combination of dutasteride (Avodart) and tamsulosin (Flomax) provides significantly greater improvement in International Prostate Symptom Score (IPSS) and patient-reported quality of life than either therapy alone in men with BPH who are at increased risk of progression, according to a 2-year analysis of data from the 4-year Combination of Avodart and Tamsulosin (CombAT) trial.

    TURP, PVP show comparable efficacy in apples-to-apples trial


    Men facing treatment for BPH can expect similar outcomes after transurethral resection of the prostate (TURP) or photoselective vaporization of the prostate (PVP), according to results of a multicenter head-to-head comparison of the two treatments, presented at the AUA annual meeting.

    Alpha-blocker raises success of trial without catheter


    A trial without catheter (TWOC) following an average of 3 days of catheterization has become standard practice in men with acute urinary retention (AUR) associated with BPH. Now the results of a study presented here have shown that the administration of an alpha-blocker prior to a TWOC can significantly increase the chances of TWOC success.

    New in-office BPH laser treatment is efficient, cost-effective


    Biolitec has launched the 150-watt Evolve side-firing diode laser unit, which the company says precisely ablates and coagulates prostate tissue, resulting in shorter procedures and recovery times.

    Use of minimally invasive BPH treatments up significantly


    Use of minimally invasive surgical treatments (MISTs) for BPH has increased tremendously in the past decade, but urologists should be careful about overusing these newer technologies, given the lack of long-term evidence of their efficacy, researchers from the University of Minnesota said here.

    TURP: Superior results confirm value in treating BPH



    A leading BPH researcher has presented data demonstrating the persistent value and utility of a time-tested treatment: monopolar transurethral resection of the prostate.

Urology Times E-News

Brings you the latest news and information twice each month.

Click here to view the E-News archives.

Sign up now to receive Urology Times E-news free of charge!

ADVERTISEMENT

Urology Times issue
Stay connected to Urology Times
Receive new issue alerts, technology bulletins, and conference updates!

ADVERTISEMENT

EVENTS CALENDAR
Contemporary Management of Chronic Pelvic Pain
July 11 - July 12
Advanced Laparoscopic Reconstructive Kidney Surgery Course
July 13 - July 14
Reconstructive Vaginal Surgery Course
July 13 - July 14
Certification Qualifying (Part 1) Exam
August 04 - August 05
AUA Foundation/Society for Basic Urology Research Summer Research Conference on Sexual Medicine
August 07 - August 09
What Do You Think?
Do you agree with an AMA committee's call to end commercial support of CME?
Yes
No
Not sure
Yes
3%
No
95%
Not sure
3%
View Results
CME SHOWCASE
Management of postoperative ileus
Management of postoperative ileus
PIN or atypical foci suspicious for PCa on biopsy: Risks and recommendations

Modern Medicine logoUrology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting UrologyTimes.com for fresh content, news, opinions, editor's blogs and more.

Click here